Login / Signup

Machine learning-driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy.

Shutong LiuPeiyu YuanYouyang ZhengChunguang GuoYuqing RenSiyuan WengYuyuan ZhangLong LiuZhe XingLibo WangXin-Wei Han
Published in: ESC heart failure (2024)
Our study revealed a number of hub genes and novel pathways to provide potential targets for the treatment of HCM. A stable model was developed, providing an efficient tool for the diagnosis of HCM.
Keyphrases
  • hypertrophic cardiomyopathy
  • left ventricular
  • machine learning
  • bioinformatics analysis
  • genome wide
  • dna methylation
  • gene expression
  • risk assessment
  • transcription factor